Serial plasma biomarkers of brain injury in infants with neonatal encephalopathy treated with therapeutic hypothermia

Meaghan M. McGowan, Alexandra C. O’Kane, Gilbert Vezina, Taeun Chang, Nicole Bendush, Penny Glass, Jiaxiang Gai, James Bost, Allen D. Everett, An N. Massaro

Research output: Contribution to journalArticlepeer-review


Background: Neonatal encephalopathy (NE) is a major cause of long-term neurodevelopmental disability in neonates. We evaluated the ability of serially measured biomarkers of brain injury to predict adverse neurological outcomes in this population. Methods: Circulating brain injury biomarkers including BDNF, IL-6, IL-8, IL-10, VEGF, Tau, GFAP, and NRGN were measured at 0, 12, 24, 48, 72, and 96 h of cooling from 103 infants with NE undergoing TH. The biomarkers’ individual and combinative ability to predict death or severe brain injury and adverse neurodevelopmental outcomes beyond 1 year of age was assessed. Results: Early measurements of inflammatory cytokines IL-6, 8, and 10 within 24 HOL (AUC = 0.826) and late measurements of Tau from 72 to 96 HOL (AUC = 0.883, OR 4.37) were accurate in predicting severe brain injury seen on MRI. Late measurements of Tau were predictive of adverse neurodevelopmental outcomes (AUC = 0.81, OR 2.59). Conclusions: Tau was consistently a predictive marker for brain injury in neonates with NE. However, in the first 24 HOL, IL-6, 8, and 10 in combination were most predictive of death or severe brain injury. The results of this study support the use of a serial biomarker panel to assess brain injury over the time course of disease in NE. Impact: While recent studies have evaluated candidate brain injury biomarkers, no biomarker is in current clinical use.This study supports the use of a serial biomarker panel for ongoing assessment of brain injury neonates with NE.In combination, IL6, IL8, and IL10 in the first 24 h of cooling were more predictive of brain injury by MRI than each cytokine alone.Individually, Tau was overall most consistently predictive of adverse neurological outcomes, particularly when measured at or after rewarming.

Original languageEnglish (US)
Pages (from-to)1228-1234
Number of pages7
JournalPediatric research
Issue number6
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Serial plasma biomarkers of brain injury in infants with neonatal encephalopathy treated with therapeutic hypothermia'. Together they form a unique fingerprint.

Cite this